117 related articles for article (PubMed ID: 30475060)
1. Butyrate-Induced In Vitro Colonocyte Differentiation Network Model Identifies ITGB1, SYK, CDKN2A, CHAF1A, and LRP1 as the Prognostic Markers for Colorectal Cancer Recurrence.
Dasgupta N; Kumar Thakur B; Chakraborty A; Das S
Nutr Cancer; 2019; 71(2):257-271. PubMed ID: 30475060
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Spleen Tyrosine Kinase (Syk) by Histone Deacetylation Promotes, Whereas BAY61-3606, a Synthetic Syk Inhibitor Abrogates Colonocyte Apoptosis by ERK Activation.
Dasgupta N; Thakur BK; Ta A; Dutta P; Das S
J Cell Biochem; 2017 Jan; 118(1):191-203. PubMed ID: 27293079
[TBL] [Abstract][Full Text] [Related]
3. Biological Characteristics and Clinical Significance of ITGB1 and RHOC in Patients With Recurrent Colorectal Cancer.
Ha YJ; Tak KH; Kim SK; Kim CW; Lee JL; Roh SA; Cho DH; Kim SY; Kim YS; Kim JC
Anticancer Res; 2019 Sep; 39(9):4853-4864. PubMed ID: 31519588
[TBL] [Abstract][Full Text] [Related]
4. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
5. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
6. Microarray Analysis of Gene Expression Involved in Butyrate-Resistant Colorectal Carcinoma HCT116 Cells.
Khonthun C; Saikachain N; Popluechai S; Kespechara K; Hiranyakas A; Srikummool M; Surangkul D
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1739-1746. PubMed ID: 32592372
[TBL] [Abstract][Full Text] [Related]
7. Polo-like kinase 1 expression is suppressed by CCAAT/enhancer-binding protein α to mediate colon carcinoma cell differentiation and apoptosis.
Dasgupta N; Thakur BK; Ta A; Das S; Banik G; Das S
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1777-1787. PubMed ID: 28341486
[TBL] [Abstract][Full Text] [Related]
8. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138
[TBL] [Abstract][Full Text] [Related]
9. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
[TBL] [Abstract][Full Text] [Related]
10. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
[TBL] [Abstract][Full Text] [Related]
12. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
Pirim D
Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
[TBL] [Abstract][Full Text] [Related]
13. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
[TBL] [Abstract][Full Text] [Related]
15. Screening for implicated genes in colorectal cancer using whole‑genome gene expression profiling.
Sun LC; Qian HX
Mol Med Rep; 2018 Jun; 17(6):8260-8268. PubMed ID: 29658574
[TBL] [Abstract][Full Text] [Related]
16. Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells.
Schwartz B; Avivi-Green C; Polak-Charcon S
Mol Cell Biochem; 1998 Nov; 188(1-2):21-30. PubMed ID: 9823007
[TBL] [Abstract][Full Text] [Related]
17. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
18. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
19. Identification of key genes in colorectal cancer using random walk with restart.
Cui X; Shen K; Xie Z; Liu T; Zhang H
Mol Med Rep; 2017 Feb; 15(2):867-872. PubMed ID: 28000901
[TBL] [Abstract][Full Text] [Related]
20. Association between PPP2CA expression and colorectal cancer prognosis tumor marker prognostic study.
Yong L; YuFeng Z; Guang B
Int J Surg; 2018 Nov; 59():80-89. PubMed ID: 30296597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]